Atrovent Inhalation Solution contains the active ingredient ipratropium bromide monohydrate. It belongs to a group of medicines called anticholinergic bronchodilators. Atrovent Inhalation Solution ...

Lupin has received approval from the Food and Drug Administration for ipratropium bromide nasal solution (nasal spray), 0.06%, which is a generic of Boehringer Ingelheim's Atrovent Nasal Spray, 0.06%.

The inhalers affected by this price cap include: - Atrovent HFA (ipratropium bromide HFA) inhalation aerosol - Combivent ...

Not currently distributed in Australia. Each 1 mL of Atrovent Adult UDV contains 522 micrograms of ipratropium bromide monohydrate (equivalent to 500 micrograms of ipratropium bromide) as the ...

Ipratropium bromide nasal solution (nasal spray), 0.06% (Atrovent) had estimated annual sales of USD 42 million in the US (IQVIA MAT November 2024). Lupin Limited is a global pharmaceutical leader ...

Ipratropium bromide 0.06% (42mcg/spray); aqueous soln. Ipratropium bromide, an anticholinergic (parasympatholytic) agent, has antisecretory properties which inhibit secretions from the serous and ...

Background: Studies have suggested an increased risk of cardiovascular morbidity and mortality associated with the use of ipratropium bromide. We sought to examine the association between ...

Ipratropium bromide 0.03% (21mcg/spray); aqueous soln. Ipratropium bromide, an anticholinergic (parasympatholytic) agent, has antisecretory properties which inhibit secretions from the serous and ...